Prostate Cancer Clinical Trials in Philadelphia

Showing 241-260 of 339 trials

COMPLETED< 1 mile

4Kscore Using Serum Stored Uncentrifuged

NCT04130776

The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure

Prostate Cancer

OPKO Health, Inc.64 participantsStarted Oct 2017

Philadelphia, Pennsylvania, United States

WITHDRAWNNA< 1 mile

Proton Therapy for High Risk Prostate Cancer

NCT01811810

The most common treatment for men with high risk prostate cancer is radiation therapy (XRT) followed by long term androgen deprivation therapy (ADT). Long-term AD is toxic, with substantial metabolic, physical, mental and sexual side-effects. In this study, the investigators propose a treatment strategy to optimize the control of high risk prostate cancer by using dose-escalated external beam radiation (proton therapy or IMRT) concurrent with docetaxel and adjuvant short-course AD. The investigators hypothesize that this approach will be superior to the current standard of care and obviate the need for long term AD. In this study, subjects will be randomized to either XRT with long term ADT or XRT and chemotherapy and short term ADT.

Prostate Cancer

Abramson Cancer Center at Penn MedicineStarted Mar 2013

Philadelphia, Pennsylvania, United States

UNKNOWNNA< 1 mile

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NCT00772317

For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)

Recurrent Prostate Cancer

SonaCare Medical117 participantsStarted Jul 2008

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +13 more locations

4Kscore Using Serum Stored Uncentrifuged

Proton Therapy for High Risk Prostate Cancer

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Prostate Cancer Trials in Other Cities

AMG 386 and Abiraterone for Advanced Prostate Cancer

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Multi-Institutional Registry for Prostate Cancer Radiosurgery

ClariCore System Used in Transperineal Prostate Biopsy

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

EXTEND Exercise Trial

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Other Conditions in Philadelphia